Brian Matthew Wolpin

机构：Brigham and Women's Hospital, Harvard University, Massachusetts General Hospital, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, Hale Family Center for Pancreatic Cancer Research · ORCID：0000-0002-0455-1032

发表论文 1255 篇 · 总被引 32294 次 · h-index 90

代表论文

• Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer (2026 · New England Journal of Medicine · 被引 87)
• Daraxonrasib, a RAS(ON) multi-selective inhibitor vs chemotherapy in previously treated metastatic pancreatic adenocarcinoma (mPDAC): Primary and final analysis from the phase 3 RASolute 302 study. (2026 · Journal of Clinical Oncology · 被引 11)
• A compendium of next-generation patient-derived models for diverse cancers (2026 · Nature · 被引 3)
• Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer (2026 · Nature Medicine · 被引 3)
• Multimodal Machine Learning for Predicting Outcomes in the PASS-01 Trial of Systemic Therapy for Metastatic Pancreatic Cancer (2026 · medRxiv)
• Immune and stromal features of durable complete response to radiation and dual immune checkpoint blockade in pancreatic cancer (2026 · medRxiv)